VC-backed Lysogene taps Clancy for board chair

French gene therapy company Lysogene has named Annette Clancy as chair of the board of directors. Currently, Clancy is the board chair of Genable Technologies Ltd and ObsEva Ltd. Lysogene’s backers include Sofinnova Partners.

122 Views

GSK buys GlycoVaxyn for $212 mln

Sofinnova Partners has sold GlycoVaxyn to GlaxoSmithKline for $212 million. Schlieren, Switzerland-based GlycoVaxyn develops conjugate vaccines to treat bacterial infections. GSK was a minority investor of GlycoVaxyn.

227 Views

Green Biologics fetches $76 mln

UK-based renewable chemicals firm Green Biologics has raised $42 million in equity funding. Swire Pacific Limited and Sofinnova Partners led the round with participation from return backers Capricorn Venture Partners, Oxford Capital Partners, Morningside Technology Partners and ConvergInce Holdings LLC. Also, Green Biologics has received $34 million in mostly debt funding led by Tennenbaum Capital Partners.

VC-backed RefleXion Medical hires new VP of engineering

RefleXion Medical has named David Q. Larkin as vice president of engineering. Previously, Larkin worked at Intuitive Surgical where he most recently served as vice president of engineering. Based in Burlingame, Calif., RefleXion Medical is a medical device company developing a biologically-guided radiation therapy system for cancer treatment. It is backed by Sofinnova Partners, Pfizer Venture Investments and Venrock.

194 Views

Pixium Vision launches IPO on Euronext Paris

Pixium Vision has launched its Initial Public Offering on Euronext’s regulated market in Paris. Based in Paris, Pixium is a maker of vision restoration systems for the blind. Its backers include Sofinnova Partners, Omnes Capital, Abingworth, Global Life Sciences Ventures, Bpifrance, Seventure and Polytechnos.

NuCana grabs $57 mln Series B funds

NuCana has raised $57 million in Series B funding. Sofinnova Ventures led the round with participation from Sofinnova Partners, Morningside Ventures, Alida Capital International and the Scottish Investment Bank, the investment arm of Scottish Enterprise. In addition to the funding, James Healy and Gerald Chan, co-founder and chairman of Morningside Ventures respectively, have been added to NuCana’s board of directors. Based in Edinburgh, NuCana is an biopharmaceutical firm focused on anti-cancer medicines.

Pixium hires new CEO and director

Pixium has appointed Khalid Ishaque as CEO and director. Previously, Ishaque worked at Boston Scientific where he most recently served as general manager of its neuromodulation international business. Based in Paris, Pixium is a maker of vision restoration systems for the blind. Its backers include Sofinnova Partners, Omnes Capital, Abingworth, Global Life Sciences Ventures, Bpifrance, Seventure and Polytechnos.

Pixium Vision raises funds led by Sofinnova

Pixium Vision, a developer of innovative retinal implant systems, has closed a Series A extension financing. This round was led by Sofinnova Partners, with support from Bpifrance, through the InnoBio fund, and existing series A investors Omnes Capital and Abingworth. In conjunction with the financing, Antoine Papiernik at Sofinnova Partners and Chahra Louafi at Bpifrance have joined the Pixium board of directors.

InnoBio Gets Backing

InnoBio, a biotech fund managed by CDC Entreprises, and Sofinnova Partners have announced a joint investment in MedDay for 8 million euros ($10.5 million). Created in 2011 by Dr Frédéric Sedel and Dr Guillaume Brion, MedDay is specialised in the treatment of neuro-metabolic diseases.

Sofinnova Partners Raises Seventh Life Sciences Fund

Sofinnova Partners has raised 240 million euros ($312 million) for its seventh life sciences venture capital fund. Sofinnova Capital VII‘s investors include leading the European Investment Fund, Skandia Life Insurance Company, CNP Assurances, and CDC Entreprises. Sofinnova Capital VII will invest about two third of its funds in European companies, and one third outside of Europe, most often in the USA.

PE HUB Community

Join the 12515 members of PE HUB to make connections, share your opinion, and follow your favorite authors.

Join the Community

Look Who’s Tweeting

PE HUB News Briefs

RSS Feed Widget

VCJ Headlines (subscribers only)

RSS Feed Widget

Buyouts Headlines (subscribers only)

RSS Feed Widget